Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G, Tarhini M, Kooshyar MM, El Hajj H, Wattel E, Mahmoudi M, Hatoum H, Rahimi H, Maleki M, Rafatpanah H, Rezaee SA, Yazdi MT, Shirdel A, de Thé H, Hermine O, Farid R, Bazarbachi A.
Kchour G, et al. Among authors: rafatpanah h.
Blood. 2009 Jun 25;113(26):6528-32. doi: 10.1182/blood-2009-03-211821. Epub 2009 May 1.
Blood. 2009.
PMID: 19411628
Free article.
Clinical Trial.